Rendia
  • How it Works
    • The Care Journey
    • Patient Acquisition
    • Pre-Appointment
    • Waiting Room
    • Exam Room
    • Post-Appointment
  • Who We Serve
    • Eye Care
    • ENT
  • Resources
    • Blog Posts
    • Downloads
    • Videos
  • Pricing
  • About
    • Our Story
    • Partnerships
    • Careers
  • Get a Demo
  • Log in
Select Page
A Treatment for an ‘Untreatable’ Blinding Condition

A Treatment for an ‘Untreatable’ Blinding Condition

by Dr. Paul Karpecki | Apr 19, 2019 | Practice Pearls

A drug for acute NAION is currently in phase III clinical trials After glaucoma, the second-most common source of optic nerve damage is Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). We usually describe this to a patient as a “stroke in the eye,” where...
Log in
How it Works
  • Patient Acquisition
  • Pre-Appointment
  • Waiting Room
  • Exam Room
  • Post-Appointment

Specialties

  • Eye Care
  • ENT

Resources

  • Downloads
  • Insights
  • Videos

About

  • Partnerships
  • Careers
  • Get a Demo
Copyright © Rendia, Inc. All Rights Reserved.

Privacy Policy

Made with ♥ in Baltimore

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.